| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/20/2023 | 300% | Cantor Fitzgerald | $3 → $2 | Downgrades | Overweight → Neutral |
| 03/29/2021 | 2300% | Truist Securities | → $12 | Initiates Coverage On | → Buy |
| 01/29/2021 | 1900% | Cantor Fitzgerald | → $10 | Initiates Coverage On | → Overweight |
| 10/30/2020 | — | William Blair | Initiates Coverage On | → Outperform |
What is the target price for Aspira Womens Health (AWH)?
The latest price target for Aspira Womens Health (NASDAQ: AWH) was reported by Cantor Fitzgerald on January 20, 2023. The analyst firm set a price target for $2.00 expecting AWH to rise to within 12 months (a possible 300.00% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aspira Womens Health (AWH)?
The latest analyst rating for Aspira Womens Health (NASDAQ: AWH) was provided by Cantor Fitzgerald, and Aspira Womens Health downgraded their neutral rating.
When is the next analyst rating going to be posted or updated for Aspira Womens Health (AWH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aspira Womens Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aspira Womens Health was filed on January 20, 2023 so you should expect the next rating to be made available sometime around January 20, 2024.
Is the Analyst Rating Aspira Womens Health (AWH) correct?
While ratings are subjective and will change, the latest Aspira Womens Health (AWH) rating was a downgraded with a price target of $3.00 to $2.00. The current price Aspira Womens Health (AWH) is trading at is $0.50, which is out of the analyst's predicted range.